Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Centrally acting muscle relaxant (substance) |
Is a |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Skeletal muscle relaxant (substance) |
Is a |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Antireumatisk middel |
Is a |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Smooth muscle relaxant (substance) |
Is a |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Uric acid drug poisoning NOS |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Other muscle drug poisoning |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
[X]Poisoning by other and unspecified drugs acting on muscles |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
lægemiddel med virkning på muskelsystemet |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
forgiftning med lægemiddelgrupper med primær effekt på det muskuloskeletale system |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Accidental probenecid poisoning |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Intentional probenecid poisoning |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
forgiftning med probenecid, uvist med hvilken hensigt |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
bivirkning af lægemiddelgrupper med primær effekt på det muskuloskeletale system |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
bivirkning af lægemiddel til behandling af arthritis urica |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Colchicum alkaloid adverse reaction |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Uricosuric agent adverse reaction (disorder) |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Probenecid adverse reaction |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Sulfinpyrazone adverse reaction |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Xanthine oxidase inhibitor adverse reaction |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Gold adverse reaction |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Sodium aurothiomalate adverse reaction |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Auranofin adverse reaction |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
allergi over for lægemidler med primær effekt på det muskuloskeletale system |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
allergi over for lægemiddel til behandling af arthritis urica |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Allergy to Colchicum alkaloid (finding) |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
allergi over for urikosrisk middel |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Allergy to probenecid |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Allergy to sulfinpyrazone |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Allergy to xanthine oxidase inhibitor |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
overdosis af lægemiddel med primær effekt på det muskuloskeletale system |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
overdosis af lægemiddel med virkning på urinsyrestofskiftet |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Gold salt overdose |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Accidental gold salt overdose |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Intentional gold salt overdose |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
overdosis af guldsalt, uvist med hvilken hensigt |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Allopurinol (substance) |
Is a |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Colchicine (substance) |
Is a |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Poisoning by probenecid |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Poisoning by uric acid metabolism drug (navigational concept) |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
hylan |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
hylan G-F 20 8 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing Colchicum alkaloid (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Adverse reaction to central nervous system muscle-tone depressants |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Adverse reaction to central nervous system muscle-tone depressants NOS |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Adverse reaction to uric acid metabolism drug NOS |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Adverse reaction to water, mineral or uric acid metabolism drug NOS |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Adverse reaction to other muscle drugs |
Causative agent |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
middel mod arthritis urica |
Is a |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing leflunomide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Penicillamine 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Penicillamine 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Penicillamine 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Leflunomide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Leflunomide 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Leflunomide 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
lægemiddelgrupper med primær effekt på det muskuloskeletale system |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing penicillamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
antireumatisk middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Penicillamine [metabolic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Drugs used in musculoskeletal/joint disorders |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Rheumatic disease suppressants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Penicillamine [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing precisely penicillamine 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Penicillamine 125 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing zafirlukast (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing leukotriene receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Aminophylline 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
aminophyllin 25 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
aminophyllin 225 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
aminophyllin 350 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
aminophyllin 100 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
aminophyllin 25 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin 10 mg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Theophylline 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin 60 mg/5 ml væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin 175 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin 250 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin kapsel med modificeret udløsning a 60 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin kapsel med modificeret udløsning a 125 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin kapsel med modificeret udløsning a 250 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin 200 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin 300 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllin 400 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Ephedrine sulfate 15 mg and theophylline 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing montelukast (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Montelukast (as montelukast sodium) 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing precisely montelukast (as montelukast sodium) 5 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Zafirlukast 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Aminophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Aminophylline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing 5-lipoxygenase inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing aminophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
theophyllinnatriumglycinat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
respirationsmuskelrelakserende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
glatmuskelrelakserende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
guaifenesin 1200 mg + pseudoephedrin 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
guaifenesin 600 mg med modificeret udløsning/pseudoephedrin 60 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Montelukast sodium 4mg oral granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
middel med virkning på det muskuloskeletale system |
Inferred relationship |
Some |
|